Literature DB >> 2205817

Episcleritis, conjunctivitis, and keratitis as ocular manifestations of Lyme disease.

A J Flach1, P E Lavoie.   

Abstract

A 35-year-old woman presented with a bilateral palpebral follicular conjunctivitis. Subsequently, she developed a bilateral keratitis and, on a separate occasion, an episcleritis that was associated with a recrudescence of Lyme disease and poor compliance with the antibiotic regimen. Both the keratitis and episcleritis cleared completely after topical corticosteroid therapy and reinstitution of appropriate antibiotic treatment. This report emphasizes the importance of collaboration between internal medicine and ophthalmologic specialists during the long-term management of Lyme disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2205817     DOI: 10.1016/s0161-6420(90)32474-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  5 in total

1.  Erythema migrans: three weeks treatment for prevention of late Lyme borreliosis.

Authors:  F Breier; G Kunz; H Klade; G Stanek; E Aberer
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

2.  Infectious scleritis: report of four cases.

Authors:  M Sainz de la Maza; R K Hemady; C S Foster
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

Review 3.  Lyme borreliosis: ten years after discovery of the etiologic agent, Borrelia burgdorferi.

Authors:  W Burgdorfer
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

Review 4.  Diagnosis and treatment of anterior uveitis: optometric management.

Authors:  Jennifer S Harthan; Dominick L Opitz; Stephanie R Fromstein; Christina E Morettin
Journal:  Clin Optom (Auckl)       Date:  2016-03-31

5.  Characteristics of Lyme optic neuritis: a case report of Lyme associated bilateral optic neuritis and systematic review of the literature.

Authors:  Yezhong Lu; Ramin Zand
Journal:  BMC Neurol       Date:  2022-03-23       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.